Shenzhen Neptunus Bioengineering Co., Ltd.

SZSE:000078 Stock Report

Market Cap: CN¥7.4b

Shenzhen Neptunus Bioengineering Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Shenzhen Neptunus Bioengineering.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth23.0%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Shenzhen Neptunus Bioengineering Co., Ltd.'s (SZSE:000078) Revenues Are Not Doing Enough For Some Investors

Oct 28
Shenzhen Neptunus Bioengineering Co., Ltd.'s (SZSE:000078) Revenues Are Not Doing Enough For Some Investors

Here's Why Shenzhen Neptunus Bioengineering (SZSE:000078) Is Weighed Down By Its Debt Load

Jul 15
Here's Why Shenzhen Neptunus Bioengineering (SZSE:000078) Is Weighed Down By Its Debt Load

There Is A Reason Shenzhen Neptunus Bioengineering Co., Ltd.'s (SZSE:000078) Price Is Undemanding

Jun 07
There Is A Reason Shenzhen Neptunus Bioengineering Co., Ltd.'s (SZSE:000078) Price Is Undemanding

Shenzhen Neptunus Bioengineering Co., Ltd.'s (SZSE:000078) Share Price Is Matching Sentiment Around Its Revenues

Mar 05
Shenzhen Neptunus Bioengineering Co., Ltd.'s (SZSE:000078) Share Price Is Matching Sentiment Around Its Revenues

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Shenzhen Neptunus Bioengineering has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SZSE:000078 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/202432,331-1,732-649-534N/A
6/30/202433,096-1,732-625-513N/A
3/31/202434,549-1,722-563-463N/A
12/31/202336,419-1,690-514-410N/A
9/30/202337,520-1,070-629-521N/A
6/30/202339,667-1,053-739-633N/A
3/31/202338,591-1,023-222-123N/A
1/1/202337,835-1,027-159-64N/A
9/30/202239,23412280367N/A
6/30/202238,93767693797N/A
3/31/202240,12173516644N/A
1/1/202241,05493737866N/A
9/30/202142,053-2752,4612,607N/A
6/30/202142,395-2761,6071,755N/A
3/31/202142,091-2761,8712,013N/A
12/31/202040,022-2891,5031,651N/A
9/30/202039,535411,8581,991N/A
6/30/202038,5081312,4642,590N/A
3/31/202039,0131532,0632,226N/A
12/31/201941,4932062,1012,269N/A
9/30/201941,260348-505-288N/A
6/30/201941,68129219243N/A
3/31/201939,723394-210-8N/A
12/31/201838,381415-1,349-1,135N/A
9/30/201836,608657-2,125-1,849N/A
6/30/201833,269727N/A-2,704N/A
3/31/201829,954697N/A-2,583N/A
1/1/201824,940636N/A-2,433N/A
9/30/201719,593602N/A-1,575N/A
6/30/201716,468554N/A-1,749N/A
3/31/201714,667471N/A-2,180N/A
12/31/201613,606418N/A-1,497N/A
9/30/201613,065352N/A-218N/A
6/30/201612,081520N/A90N/A
3/31/201611,572487N/A266N/A
12/31/201511,118475N/A91N/A
9/30/201510,809320N/A-516N/A
6/30/201510,50526N/A-299N/A
3/31/201510,17725N/A-223N/A
12/31/20149,80224N/A-117N/A
9/30/20149,293113N/A-191N/A
6/30/20148,922119N/A-39N/A
3/31/20148,427119N/A-284N/A
12/31/20137,993117N/A-123N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 000078's forecast earnings growth is above the savings rate (2.8%).

Earnings vs Market: Insufficient data to determine if 000078's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 000078's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 000078's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 000078's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 000078's Return on Equity is forecast to be high in 3 years time


Discover growth companies